Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Blocklisting Six Monthly Return

4 Dec 2012 15:40

RNS Number : 7318S
Ark Therapeutics Group PLC
04 December 2012
 



 

Ark Therapeutics Group plc

4 December 2012

 

BLOCKLISTING SIX MONTHLY RETURN

 

1. Name of applicant

Ark Therapeutics Group plc

 

2. Name of scheme

Ark Therapeutics Group Unapproved Share Option Scheme

 

3. Period of return

From 03/06/2012 - 03/12/2012

 

4. Balance of unallotted securities under scheme from previous return

2,271,252

 

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

 

6. Less: Number of securities issued/allotted under the scheme during period

Nil

 

7. Equals: Balance under the scheme not yet issued/allotted at end of period

2,271,252

 

BLOCKLISTING SIX MONTHLY RETURN

 

1. Name of applicant

Ark Therapeutics Group plc

 

2. Name of scheme

Ark Therapeutics Group Enterprise Management Incentive Share Option Plan

 

3. Period of return

From 03/06/2012 - 03/12/2012

 

4. Balance of unallotted securities under scheme from previous return

939,433

 

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

 

6. Less: Number of securities issued/allotted under the scheme during period

Nil

 

7. Equals: Balance under the scheme not yet issued/allotted at end of period

939,433

 

BLOCKLISTING SIX MONTHLY RETURN

 

1. Name of applicant

Ark Therapeutics Group plc

 

2. Name of scheme

Ark Therapeutics Group 2005 Long Term Incentive Plan

 

3. Period of return

From 03/06/2012 - 03/12/2012

 

4. Balance of unallotted securities under scheme from previous return

683,200

 

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

 

6. Less: Number of securities issued/allotted under the scheme during period

Nil

 

7. Equals: Balance under the scheme not yet issued/allotted at end of period

683,200

 

BLOCKLISTING SIX MONTHLY RETURN

 

1. Name of applicant

Ark Therapeutics Group plc

 

2. Name of scheme

Ark Therapeutics Group Approved Share Option Plan

 

3. Period of return

From 03/06/2012 - 03/12/2012

 

4. Balance of unallotted securities under scheme from previous return

1,000,000

 

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

 

6. Less: Number of securities issued/allotted under the scheme during period

Nil

 

7. Equals: Balance under the scheme not yet issued/allotted at end of period

1,000,000

 

 

Name of contact:

Sue Steven, Company Secretary

Telephone number of contact:

0207 388 7722

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUSOVRUKAURAA
Date   Source Headline
22nd Apr 20093:34 pmRNSAGM Results
7th Apr 200911:09 amRNSAnnual Information Update
7th Apr 20097:00 amRNSResearch Update
17th Mar 20095:03 pmRNSHolding(s) in Company
13th Mar 20094:25 pmRNSHolding(s) in Company
11th Mar 20097:00 amRNSFinal Results
2nd Mar 200911:21 amRNSVoting Rights and Capital
26th Feb 20097:00 amRNSPatent Filing
17th Feb 20092:14 pmRNSHolding(s) in Company
16th Feb 20095:39 pmRNSHolding(s) in Company
16th Feb 20097:00 amRNSResearch Update
5th Feb 200910:50 amRNSDealing by Employee Benefit Trust
2nd Feb 20097:00 amRNSDirector/PDMR Shareholding
21st Jan 20094:40 pmRNSSecond Price Monitoring Extn
21st Jan 20094:37 pmRNSPrice Monitoring Extension
21st Jan 200912:12 pmRNSNotice of Results
14th Jan 20097:00 amRNSRe Agreement
9th Jan 200910:23 amRNSHolding(s) in Company
8th Jan 20097:00 amRNSTrinam Phase III trial to commence
6th Jan 20097:00 amRNSResearch Update
31st Dec 20089:00 amRNSTotal Voting Rights
16th Dec 20083:46 pmRNSNotification of Major Interests in Shares
9th Dec 20084:40 pmRNSSecond Price Monitoring Extn
9th Dec 20084:35 pmRNSPrice Monitoring Extension
9th Dec 20087:00 amRNSRegulatory Approval
5th Dec 20082:28 pmRNSBlocklisting Six Monthly Return
1st Dec 20087:00 amRNSRegulatory Application
24th Nov 200811:58 amRNSDirector/PDMR Shareholding
13th Nov 20087:00 amRNSInterim Management Statement
20th Oct 20087:00 amRNSProduct Launch
2nd Oct 20087:00 amRNSArk secures reimbursement for Neuropad
30th Sep 20085:06 pmRNSVoting Rights and Capital
17th Sep 20081:08 pmRNSHolding(s) in Company
27th Aug 20087:00 amRNSInterim Results
27th Aug 20087:00 amRNSResearch Update
26th Aug 20084:08 pmRNSHolding(s) in Company
1st Aug 200810:47 amRNSVoting Rights and Captial
31st Jul 20081:12 pmRNSHolding(s) in Company
30th Jul 20087:00 amRNSResearch Update
16th Jul 20087:00 amRNSResearch Update
8th Jul 200811:00 amRNSArk opens new manufacturing f
24th Jun 200811:28 amRNSHolding(s) in Company
18th Jun 20087:00 amRNSResearch Update
6th Jun 200812:10 pmRNSBlocklisting Application
3rd Jun 200810:58 amRNSBlocklisting Interim Review
3rd Jun 200810:51 amRNSBlocklisting Interim Review
2nd Jun 20087:00 amRNSRegulatory Approval
30th May 20084:52 pmRNSVoting Rights and Capital
30th May 20087:00 amRNSResearch Update
22nd May 20081:27 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.